BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33879127)

  • 1. Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment.
    Al-Aamri HM; Irving HR; Bradley C; Meehan-Andrews T
    BMC Cancer; 2021 Apr; 21(1):438. PubMed ID: 33879127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.
    Al-Aamri HM; Ku H; Irving HR; Tucci J; Meehan-Andrews T; Bradley C
    BMC Cancer; 2019 Feb; 19(1):179. PubMed ID: 30813936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combing metabolomics with bioanalysis methods to study the antitumor mechanism of the new acridone derivative 8q on CCRF-CEM cells: 8q induced mitochondrial-mediated apoptosis and targeted the PI3K/AKT/FOXO1 pathway.
    Wang N; Zhang B; Jin F; Gao D; Liu F; Liu H; Jiang Y
    J Pharm Biomed Anal; 2018 Oct; 160():314-322. PubMed ID: 30114609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the DNA repair pathways utilised by acute lymphoblastic leukaemia cells following daunorubicin treatment.
    Al-Aamri HM; Irving HR; Meehan-Andrews T; Bradley C
    BMC Res Notes; 2019 Sep; 12(1):625. PubMed ID: 31551083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin.
    Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
    Anticancer Res; 2013 Oct; 33(10):4439-43. PubMed ID: 24123013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells.
    Belloc F; Belaud-Rotureau MA; Lavignolle V; Bascans E; Braz-Pereira E; Durrieu F; Lacombe F
    Cytometry; 2000 Jun; 40(2):151-60. PubMed ID: 10805935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative potential of a novel parthenin analog P16 as evident by apoptosis accompanied by down-regulation of PI3K/AKT and ERK pathways in human acute lymphoblastic leukemia MOLT-4 cells.
    Goswami A; Shah BA; Kumar A; Rizvi MA; Kumar S; Bhushan S; Malik FA; Batra N; Joshi A; Singh J
    Chem Biol Interact; 2014 Oct; 222():60-7. PubMed ID: 25196075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-3-like activity is necessary but not sufficient for daunorubicin-induced apoptosis in Jurkat human lymphoblastic leukemia cells.
    Turnbull KJ; Brown BL; Dobson PR
    Leukemia; 1999 Jul; 13(7):1056-61. PubMed ID: 10400421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance.
    Lotfi K; Zackrisson AL; Peterson C
    Cancer Lett; 2002 Apr; 178(2):141-9. PubMed ID: 11867198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and apoptotic effects of prenylflavonoid artonin B in human acute lymphoblastic leukemia cells.
    Lee CC; Lin CN; Jow GM
    Acta Pharmacol Sin; 2006 Sep; 27(9):1165-74. PubMed ID: 16923337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of intrinsic and extrinsic apoptosis pathways in the human leukemic MOLT-4 cell line by terpinen-4-ol.
    Khaw-on P; Banjerdpongchai R
    Asian Pac J Cancer Prev; 2012; 13(7):3073-6. PubMed ID: 22994712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Huaier Aqueous Extract Combined with Routine Chemo-therapeutic Drugs on Human Acute Lymphoblastic Leukemia Cells Nalm-6 and Sup-B15].
    Qu P; Zhou F; Tan LF; Wang ZJ; Wang ML; Jin RM; Han J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1451-1458. PubMed ID: 33067936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium.
    Jow GM; Chou CJ; Chen BF; Tsai JH
    Cancer Lett; 2004 Dec; 216(2):165-73. PubMed ID: 15533592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
    Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia.
    Du X; Tong J; Lu H; He C; Du S; Jia P; Zhao W; Xu H; Li J; Shen Z; Wu Y; Tong J; Zhou L
    Mol Med Rep; 2017 Jul; 16(1):101-108. PubMed ID: 28487980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
    Zhang X; Huang H; Xu Z; Zhan R
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells.
    Nakaoka E; Tanaka S; Onda K; Sugiyama K; Hirano T
    Anticancer Res; 2015 Nov; 35(11):6041-8. PubMed ID: 26504027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20S-Ginsenoside Rh2 induces apoptosis in human Leukaemia Reh cells through mitochondrial signaling pathways.
    Xia T; Wang JC; Xu W; Xu LH; Lao CH; Ye QX; Fang JP
    Biol Pharm Bull; 2014; 37(2):248-54. PubMed ID: 24492721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.